Insufficient involvement of psychiatrists in substitution treatment;Die unzureichende beteiligung von psychiatern an der substitutionsbehandlung

Nervenarzt

Volumn 77, Issue 11, 2006, Pages 1368-1372

  Soyka, M ^a,b   Apelt, S M ^c   Wittchen, H U ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b Privatklinik Meiringen ^*  (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Buprenorphine; Drug dependence; Methadone; Public health

Indexed keywords

OPIATE;

COMORBIDITY; DRUG DEPENDENCE; GENERAL PRACTITIONER; HUMAN; MENTAL DISEASE; OUTPATIENT; PHYSICIAN; PRIVATE PRACTICE; PSYCHIATRIST; PSYCHOTHERAPY; REVIEW; SUBSTITUTION THERAPY;

COMORBIDITY; GERMANY; HUMANS; MENTAL DISORDERS; METHADONE; OPIOID-RELATED DISORDERS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; PREVALENCE; PSYCHIATRY; RISK ASSESSMENT; RISK FACTORS;

EID: 33750896668     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-006-2149-0     Document Type: Review

References (15)

1. Bühringer G, Kröger C, Lieb R et al. (2002) Suchtforschungsverbund ASAT: Entwicklung von Zuordnungsmodellen für Interventionen bei Substanzstörungen. Sucht 48: 200-208
2. Davies A, Huxley P (1997) Survey of general practioners' opinions on treatment of opiate users. BMJ 314: 1173
3. Die Drogenbeauftragte der Bundesregierung (2005) Drogen- und Suchtbericht 2005
4. Matheson C, Pitcairn J, Bond CM et al. (2003) General practice management of illicit users in Scotland: a national survey. Addiction 98: 119-126
5. Pelet A, Besson J, Pecoud A et al. (2005) Difficulties associated with outpatient management of drug abusers by general practitioners. A cross-sectional survey of general practitioners with and without methadone patients in Switzerland. BMC Fam Pract 6: 51
6. Soyka M, Banzer K, Buchberger R et al. (1997) Methadon-Substitution Opioidabhängiger - Katamnestische Ergebnisse und klinische Erfahrungen eines 7jährigen wissenschaftlichen Forschungsprojekts. Nervenheilkunde 16: 347-352
7. Soyka M, Banzer K, Erbas B et al. (2006) Substitutionsbehandlung Drogenabhängiger - Rechtliche Grundlagen und neue Ergebnisse der Therapieforschung. Nervenheilkunde 25: 286-294
8. Soyka M, Penning C, Wittchen HU (2006) Fatal poisoning in methadone and buprenorphine treated patients - are there differences? Pharmacopsychiatry 39: 85-87
9. Soyka Am, Apelt SM, Lieb M, Wittichen HU (2006) One year mortality rates in methadone and buprenorphine maintenance therapy: A nationally representative cohort study in 2,694 patients. I Clin Psychopharmacol (in progress)
10. Strang J, Sheridan J, Hunt C et al. (2005) The prescribing of methadone and other opioids to addicts: national survey of GPs in England and Wales. Br J Gen Pract 55: 444-451
11. Vollmer HC, Kraut HJ (2001) Therapie der Drogenabhängigkeit. In: Tretter F, Müller A (Hrsg) Psychologische Therapie der Sucht. Hogrefe, Göttingen, S 395-438
12. Wechsberg WM, Flannery B, Kasten JJ et al. (2004) Physicians practicing in methadone treatment programs: Who are they and what do they do? J Addict Dis 23: 15-31
13. Wittchen HU, Apelt SM, Christl B et al. (2004) Die Versorgungspraxis der Substitutionstherapie Opiatabhängiger (COBRA). Suchtmed 6: 80-87
14. Wittchen HU, Apelt SM, Bühringer G et al. (2005) Buprenorphine and methadone in the treatment of opioid dependence: methods and design of the COBRA study. Int J Methods Psychiatr Res 14: 14-28
15. Wittchen HU, Apelt SM, Mühlig S (2005) Die Versorgungslage der Substitutionstherapie. In Gerlach R, Stöver H (Hrsg) Vom Tabu zur Normalität. 20 Jahre Substitution in Deutschland. Zwischenbilanz und Aufgaben für die Zukunft. Lambertus, Freiburg